跳至主要内容
临床试验/NCT01321476
NCT01321476撤回不适用

Contribution of Hepatic and Intestinal Lipoproteins to Human Atherosclerosis

Piedmont Healthcare0 个研究点开始时间: 2011年3月23日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Demonstrated Plaques

研究概览

简要总结

This study will use excess tissue from endoscopic or surgical procedures to examine the elements of plaque that are found in the carotid walls of patients who have a type of heart and blood vessel disease called atherosclerosis. Tissue will be collected from patients undergoing carotid procedures as well as patients undergoing liver and/or intestinal biopsies. This lab study will examine the different types of proteins that play a role in developing heart plaque.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years
  • Scheduled for a clinically indicated, standard-of-care carotid endarterectomy (CEA) OR scheduled for a clinically indicated, standard-of- care surgical, laparoscopic or endoscopic intestinal biopsy or excision OR scheduled for a clinically indicated, standard-of-care surgical, laparoscopic or endoscopic liver biopsy or partial resection/excision
  • Ability and willingness to consent and Authorization for use of PHI

排除标准

  • Age ≤18 years
  • Inability or unwillingness to consent and Authorization for use of PHI
  • FOR CAROTID PATIENTS - history of carotid trauma, that is determined by the Principal Investigator to significantly have changed the carotid tissue structure
  • FOR CAROTID PATIENTS - history of middle- or large-vessel vasculitis, that is determined by the Principal Investigator to significantly have changed the carotid tissue structure

结局指标

主要结局

Demonstrated Plaques

时间窗: up to 30 months

Presence of both liver and intestinally derived lipoprotein particles demonstrated in human atherosclerotic plaques.

次要结局

未报告次要终点

研究者

申办方类型
Other

相似试验